RE:Earning Next Week??Dunno if I'd call it a bad quatert per se. Vimovo royalties came in higher than estimated but nobody was ready for the sticker price of:
a) changing company direction
b) moving to Ireland
c) CEO changeover
I suspect Q4 revenues will also be higher than most people expect as they have indicated they will be hiring between 20-25 drug reps to start promoting Yosprala, but there will be no income to offset the salary costs. Shall see.